tiprankstipranks
Trending News
More News >
Acadia Healthcare (ACHC)
NASDAQ:ACHC
US Market

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Compare
371 Followers
See the Price Targets and Ratings of:

ACHC Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
6 Buy
5 Hold
1 Sell
Based on 12 analysts giving stock ratings to
Acadia
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ACHC Stock 12 Month Forecast

Average Price Target

$18.91
▲(40.69% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Acadia Healthcare in the last 3 months. The average price target is $18.91 with a high forecast of $27.00 and a low forecast of $13.00. The average price target represents a 40.69% change from the last price of $13.44.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","29":"$29","46":"$46","20.5":"$20.5","37.5":"$37.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.909090909090907,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,20.5,29,37.5,46],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.44,14.483076923076922,15.526153846153846,16.569230769230767,17.61230769230769,18.655384615384612,19.698461538461537,20.74153846153846,21.784615384615385,22.827692307692306,23.870769230769227,24.91384615384615,25.956923076923076,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.44,13.8606993006993,14.281398601398601,14.7020979020979,15.122797202797202,15.543496503496502,15.964195804195803,16.384895104895104,16.805594405594405,17.226293706293703,17.646993006993007,18.067692307692305,18.488391608391606,{"y":18.909090909090907,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.44,13.406153846153845,13.372307692307691,13.338461538461537,13.304615384615385,13.27076923076923,13.236923076923077,13.203076923076923,13.169230769230769,13.135384615384615,13.101538461538462,13.067692307692308,13.033846153846154,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":45.11,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.98,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.93,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.78,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.63,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.45,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.55,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.84,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.19,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.44,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$27.00Average Price Target$18.91Lowest Price Target$13.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$34$15
Hold
11.61%
Upside
Downgraded
01/22/26
Acadia Healthcare downgraded to Hold from Buy at JefferiesAcadia Healthcare downgraded to Hold from Buy at Jefferies
Barclays
$14
Hold
4.17%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (NASDAQ: ACHC) and Ascendis Pharma (NASDAQ: ASND)
Mizuho Securities Analyst forecast on ACHC
Mizuho Securities
Mizuho Securities
Hold
Reiterated
01/21/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: AbbVie (NYSE: ABBV) and Acadia Healthcare (NASDAQ: ACHC)
TD Cowen
$25$22
Buy
63.69%
Upside
Reiterated
01/15/26
Maintaining a Buy on Acadia Healthcare: Valuation Upside and Resilient Medium-Term Growth Despite PLGL-Driven 2025 Reset
RBC Capital Analyst forecast on ACHC
RBC Capital
RBC Capital
$19$17
Buy
26.49%
Upside
Reiterated
01/14/26
RBC Capital Keeps Their Buy Rating on Acadia Healthcare (ACHC)
UBS
$28$24
Buy
78.57%
Upside
Reiterated
12/03/25
Acadia Healthcare price target lowered to $24 from $28 at UBSAcadia Healthcare price target lowered to $24 from $28 at UBS
Deutsche Bank  Analyst forecast on ACHC
Deutsche Bank
Deutsche Bank
$33$20
Buy
48.81%
Upside
Reiterated
12/03/25
Acadia Healthcare price target lowered to $20 from $33 at Deutsche BankAcadia Healthcare price target lowered to $20 from $33 at Deutsche Bank
Leerink Partners Analyst forecast on ACHC
Leerink Partners
Leerink Partners
$14
Hold
4.17%
Upside
Downgraded
12/03/25
Acadia Healthcare downgraded to Market Perform from Outperform at LeerinkAcadia Healthcare downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on ACHC
Bank of America Securities
Bank of America Securities
$21.5$13
Sell
-3.27%
Downside
Downgraded
12/03/25
Acadia Healthcare downgraded to Underperform from Neutral at BofAAcadia Healthcare downgraded to Underperform from Neutral at BofA
KeyBanc
$30$25
Buy
86.01%
Upside
Reiterated
12/03/25
Acadia Healthcare price target lowered to $25 from $30 at KeyBancAcadia Healthcare price target lowered to $25 from $30 at KeyBanc
Cantor Fitzgerald Analyst forecast on ACHC
Cantor Fitzgerald
Cantor Fitzgerald
$22$17
Hold
26.49%
Upside
Reiterated
12/02/25
Acadia Healthcare price target lowered to $17 from $22 at Cantor FitzgeraldAcadia Healthcare price target lowered to $17 from $22 at Cantor Fitzgerald
Guggenheim Analyst forecast on ACHC
Guggenheim
Guggenheim
$29$27
Buy
100.89%
Upside
Reiterated
11/07/25
Acadia Healthcare price target lowered to $27 from $29 at GuggenheimAcadia Healthcare price target lowered to $27 from $29 at Guggenheim
Raymond James Analyst forecast on ACHC
Raymond James
Raymond James
$30
Buy
123.21%
Upside
Reiterated
10/03/25
Raymond James Keeps Their Buy Rating on Acadia Healthcare (ACHC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$34$15
Hold
11.61%
Upside
Downgraded
01/22/26
Acadia Healthcare downgraded to Hold from Buy at JefferiesAcadia Healthcare downgraded to Hold from Buy at Jefferies
Barclays
$14
Hold
4.17%
Upside
Reiterated
01/22/26
Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (NASDAQ: ACHC) and Ascendis Pharma (NASDAQ: ASND)
Mizuho Securities Analyst forecast on ACHC
Mizuho Securities
Mizuho Securities
Hold
Reiterated
01/21/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: AbbVie (NYSE: ABBV) and Acadia Healthcare (NASDAQ: ACHC)
TD Cowen
$25$22
Buy
63.69%
Upside
Reiterated
01/15/26
Maintaining a Buy on Acadia Healthcare: Valuation Upside and Resilient Medium-Term Growth Despite PLGL-Driven 2025 Reset
RBC Capital Analyst forecast on ACHC
RBC Capital
RBC Capital
$19$17
Buy
26.49%
Upside
Reiterated
01/14/26
RBC Capital Keeps Their Buy Rating on Acadia Healthcare (ACHC)
UBS
$28$24
Buy
78.57%
Upside
Reiterated
12/03/25
Acadia Healthcare price target lowered to $24 from $28 at UBSAcadia Healthcare price target lowered to $24 from $28 at UBS
Deutsche Bank  Analyst forecast on ACHC
Deutsche Bank
Deutsche Bank
$33$20
Buy
48.81%
Upside
Reiterated
12/03/25
Acadia Healthcare price target lowered to $20 from $33 at Deutsche BankAcadia Healthcare price target lowered to $20 from $33 at Deutsche Bank
Leerink Partners Analyst forecast on ACHC
Leerink Partners
Leerink Partners
$14
Hold
4.17%
Upside
Downgraded
12/03/25
Acadia Healthcare downgraded to Market Perform from Outperform at LeerinkAcadia Healthcare downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on ACHC
Bank of America Securities
Bank of America Securities
$21.5$13
Sell
-3.27%
Downside
Downgraded
12/03/25
Acadia Healthcare downgraded to Underperform from Neutral at BofAAcadia Healthcare downgraded to Underperform from Neutral at BofA
KeyBanc
$30$25
Buy
86.01%
Upside
Reiterated
12/03/25
Acadia Healthcare price target lowered to $25 from $30 at KeyBancAcadia Healthcare price target lowered to $25 from $30 at KeyBanc
Cantor Fitzgerald Analyst forecast on ACHC
Cantor Fitzgerald
Cantor Fitzgerald
$22$17
Hold
26.49%
Upside
Reiterated
12/02/25
Acadia Healthcare price target lowered to $17 from $22 at Cantor FitzgeraldAcadia Healthcare price target lowered to $17 from $22 at Cantor Fitzgerald
Guggenheim Analyst forecast on ACHC
Guggenheim
Guggenheim
$29$27
Buy
100.89%
Upside
Reiterated
11/07/25
Acadia Healthcare price target lowered to $27 from $29 at GuggenheimAcadia Healthcare price target lowered to $27 from $29 at Guggenheim
Raymond James Analyst forecast on ACHC
Raymond James
Raymond James
$30
Buy
123.21%
Upside
Reiterated
10/03/25
Raymond James Keeps Their Buy Rating on Acadia Healthcare (ACHC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Acadia Healthcare

3 Months
xxx
Success Rate
23/39 ratings generated profit
59%
Average Return
+2.69%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.97% of your transactions generating a profit, with an average return of +2.69% per trade.
1 Year
John RansomRaymond James
Success Rate
14/39 ratings generated profit
36%
Average Return
+3.88%
reiterated a buy rating 4 months ago
Copying John Ransom's trades and holding each position for 1 Year would result in 35.90% of your transactions generating a profit, with an average return of +3.88% per trade.
2 Years
xxx
Success Rate
17/39 ratings generated profit
44%
Average Return
+15.57%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 43.59% of your transactions generating a profit, with an average return of +15.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ACHC Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
5
1
4
5
4
Buy
7
8
9
8
4
Hold
7
8
10
12
9
Sell
0
0
1
1
1
Strong Sell
0
0
0
0
0
total
19
17
24
26
18
In the current month, ACHC has received 8 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. ACHC average Analyst price target in the past 3 months is 18.91.
Each month's total comprises the sum of three months' worth of ratings.

ACHC Financial Forecast

ACHC Earnings Forecast

Next quarter’s earnings estimate for ACHC is <$0.01 with a range of -$0.02 to $0.04. The previous quarter’s EPS was $0.72. ACHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year ACHC has Performed in-line its overall industry.
Next quarter’s earnings estimate for ACHC is <$0.01 with a range of -$0.02 to $0.04. The previous quarter’s EPS was $0.72. ACHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year ACHC has Performed in-line its overall industry.

ACHC Sales Forecast

Next quarter’s sales forecast for ACHC is $800.20M with a range of $789.10M to $812.42M. The previous quarter’s sales results were $851.57M. ACHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year ACHC has Performed in-line its overall industry.
Next quarter’s sales forecast for ACHC is $800.20M with a range of $789.10M to $812.42M. The previous quarter’s sales results were $851.57M. ACHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year ACHC has Performed in-line its overall industry.

ACHC Stock Forecast FAQ

What is ACHC’s average 12-month price target, according to analysts?
Based on analyst ratings, Acadia Healthcare’s 12-month average price target is 18.91.
    What is ACHC’s upside potential, based on the analysts’ average price target?
    Acadia Healthcare has 40.69% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ACHC a Buy, Sell or Hold?
          Acadia Healthcare has a consensus rating of Moderate Buy which is based on 6 buy ratings, 5 hold ratings and 1 sell ratings.
            What is Acadia Healthcare’s price target?
            The average price target for Acadia Healthcare is 18.91. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $27.00 ,the lowest forecast is $13.00. The average price target represents 40.69% Increase from the current price of $13.44.
              What do analysts say about Acadia Healthcare?
              Acadia Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of ACHC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.